Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary immunity and vaccine failure after live attenuated influenza vaccine in HIV infection
2014-001924-31Phase 2Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Differential gene expression profiles after LAIV. Started Apr 2019; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-001924-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001924-31.